News
Stockhead on MSN10h
Biocurious: It’s a case of animal magnetism as Island eyes the FDA’s new rule on non-human testing
Island Pharmaceuticals hopes the US FDA will approve its acquired asset Galidesivir on the back of animal testing alone.
Although outbreaks of Ebola virus are rare, the disease is severe and often fatal, with few treatment options. Rather than ...
Oxford Mail on MSN4d
Duke of Gloucester visits University of Oxford's vaccine facilities
The Duke of Gloucester has visited the University of Oxford to tour two of its leading medical research centres. Prince ...
Aptitude Medical Systems (Aptitude™) announced today its second major partnership with the Biomedical Advanced Research and ...
SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...
The broad-spectrum drug targets deadly viruses like Ebola, Marburg, and Zika, and Island plans to pursue FDA approval under the "animal rule" pathway -potentially making it just one animal study ...
Long Shortz with Island Pharma: Targeting Ebola, Zika & Marburg with Gallidesivir Island Pharmaceuticals has acquired the Galidevsivir program from NASDAQ-listed BioCryst Pharmaceuticals.
Long Shortz with Island Pharma: Targeting Ebola, Zika & Marburg with Gallidesivir Island Pharmaceuticals has acquired the Galidevsivir program from NASDAQ-listed BioCryst Pharmaceuticals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback